Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-11
DOI
10.1038/s41467-021-22885-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
- (2020) Katrin Aslan et al. Nature Communications
- Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes
- (2020) Ekaterina Friebel et al. CELL
- Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
- (2020) Florian Klemm et al. CELL
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
- (2020) Jasneet Kaur Khalsa et al. Nature Communications
- Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
- (2020) Ying Jing et al. Nature Communications
- Fate mapping via CCR2-CreER mice reveals monocyte-to-microglia transition in development and neonatal stroke
- (2020) Hong-Ru Chen et al. Science Advances
- Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
- (2020) Lakshmi Nayak et al. CLINICAL CANCER RESEARCH
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
- (2019) Junfei Zhao et al. NATURE MEDICINE
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
- (2019) Kurt A. Schalper et al. NATURE MEDICINE
- Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy
- (2019) Mauro Di Pilato et al. NATURE
- Rational design of anti-GITR-based combination immunotherapy
- (2019) Roberta Zappasodi et al. NATURE MEDICINE
- Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
- (2019) Maisa C. Takenaka et al. NATURE NEUROSCIENCE
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities
- (2019) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- The function and dysfunction of memory CD8+ T cells in tumor immunity
- (2018) James L. Reading et al. IMMUNOLOGICAL REVIEWS
- Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma
- (2018) Dipongkor Saha et al. Immunotherapy
- Tissue-resident memory T cells at the center of immunity to solid tumors
- (2018) Derk Amsen et al. NATURE IMMUNOLOGY
- Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR
- (2018) David Zemmour et al. NATURE IMMUNOLOGY
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Comparative transcriptome analysis reveals distinct genetic modules associated with Helios expression in intratumoral regulatory T cells
- (2018) Kathleen Yates et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Signaling by the Epstein–Barr virus LMP1 protein induces potent cytotoxic CD4+and CD8+T cell responses
- (2018) Il-Kyu Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
- (2018) Pakawat Chongsathidkiet et al. NATURE MEDICINE
- Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models
- (2018) Vassilis Genoud et al. OncoImmunology
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery
- (2018) Minako Ito et al. NATURE
- Relationship between CD4 Regulatory T Cells and Anergy In Vivo
- (2017) Lokesh A. Kalekar et al. JOURNAL OF IMMUNOLOGY
- FoxP3 scanning mutagenesis reveals functional variegation and mild mutations with atypical autoimmune phenotypes
- (2017) Ho-Keun Kwon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression
- (2016) Henrik N. Kløverpris et al. IMMUNITY
- CD4+ T cell anergy prevents autoimmunity and generates regulatory T cell precursors
- (2016) Lokesh A Kalekar et al. NATURE IMMUNOLOGY
- Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
- (2016) Teresa E. Peterson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
- (2016) Jonas Kloepper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity
- (2016) Hidetoshi Nakagawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma
- (2016) Abhishek D. Garg et al. Science Translational Medicine
- Understanding the Role of T Cells in CNS Homeostasis
- (2016) Erik Ellwardt et al. TRENDS IN IMMUNOLOGY
- Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
- (2016) Mira A. Patel et al. Journal for ImmunoTherapy of Cancer
- Efficient entry of cell-penetrating peptide nona-arginine into adherent cells involves a transient increase in intracellular calcium
- (2015) K. Melikov et al. BIOCHEMICAL JOURNAL
- Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment
- (2015) Vasileios Askoxylakis et al. JNCI-Journal of the National Cancer Institute
- Stable inhibitory activity of regulatory T cells requires the transcription factor Helios
- (2015) H.-J. Kim et al. SCIENCE
- CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
- (2015) Prakash K. Gupta et al. PLoS Pathogens
- Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment
- (2015) Vasileios Askoxylakis et al. JNCI-Journal of the National Cancer Institute
- Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma
- (2014) S Han et al. BRITISH JOURNAL OF CANCER
- Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
- (2014) Manuel Valiente et al. CELL
- Immunocompetent murine models for the study of glioblastoma immunotherapy
- (2014) Taemin Oh et al. Journal of Translational Medicine
- Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
- (2014) Anna Sophie Berghoff et al. NEURO-ONCOLOGY
- Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model
- (2013) T. A. Cheema et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human Regulatory T Cells Kill Tumor Cells through Granzyme-Dependent Cytotoxicity upon Retargeting with a Bispecific Antibody
- (2013) B. D. Choi et al. Cancer Immunology Research
- GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability
- (2013) D. A. Schaer et al. Cancer Immunology Research
- Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells
- (2012) T. Duhen et al. BLOOD
- A Mouse Model of the Most Aggressive Subgroup of Human Medulloblastoma
- (2012) Daisuke Kawauchi et al. CANCER CELL
- Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy
- (2012) C. A. Crane et al. NEURO-ONCOLOGY
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
- (2011) H. Wakimoto et al. NEURO-ONCOLOGY
- Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy
- (2010) David Coe et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation
- (2010) Adam D. Cohen et al. PLoS One
- Akt-Dependent Proapoptotic Effects of Dietary Restriction on Late-Stage Management of a Phosphatase and Tensin Homologue/Tuberous Sclerosis Complex 2-Deficient Mouse Astrocytoma
- (2008) J. Marsh et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation